Holden Leads Blog

Cannabis Industry Insights

Data, outreach strategies, and market intelligence for cannabis B2B professionals.

July 3, 2026

Cannabis Earnings 2026: Who's Profitable, Who's Squeezed

Q1 2026 cannabis earnings split the big operators: Green Thumb grew revenue, Trulieve shrank but printed cash. Here's what it means for who can buy.

Read more →
July 2, 2026

Minor Cannabinoids Are 2026's Breakout Product Category

CBN, CBG, and THCV are 2026's anticipated breakout, with shoppers buying by blend over strain name. Here's what it means for dispensary shelves.

Read more →
June 30, 2026

How to Reach Dispensary Owners, Not the Front Desk

Most cannabis B2B outreach dies at the front desk. Here's how to reach the dispensary owner who can actually say yes, and why your channel matters.

Read more →
June 29, 2026

Cannabis Rescheduling Update: What the June 29 Hearing Means

DEA marijuana rescheduling hearing starts June 29, 2026. See what Schedule III already changed for licensed dispensaries, and what's still in play.

Read more →
June 25, 2026

A Sobering Week for Cannabis Science; Why "It's Complicated" Is the Honest Headline

It was a humbling week for anyone who likes their cannabis science tidy. A major international study suggested that how a country legalizes matters more than whether it does.

Read more →
June 24, 2026

Hype-Strain Genetics and 5mg Seltzers. How Summer 2026's Product Drops Reveal a Bifurcating Market

Walk into a dispensary this June and you can see two cannabis industries sharing the same shelf. On one side sit the trophy strains: small-batch, terpene-loud, genetics-obsessed flower that connoisseurs hunt by name.

Read more →
June 23, 2026

The Clock Runs Down on Two Federal Deadlines That Will Define Cannabis for Years

Cannabis policy in the United States is being shaped this summer not by a single dramatic vote but by two ticking clocks, and this week pushed both closer to zero.

Read more →
June 22, 2026

Earnings Season Splits the Industry in Two Record Revenue for the Disciplined, Fire Sales for the Over-leveraged

If you wanted a single snapshot of where the cannabis business stands in mid-2026, you could not have asked for a clearer one than the run of financial filings that landed this week.

Read more →
June 18, 2026

A 240-Patient Study Makes the Case That Cannabis Can Spare Opioids

The most clinically meaningful cannabis study of the week did not involve a flashy molecule or a dramatic cure. It involved 240 patients living with a poorly understood, chronically painful condition

Read more →
June 17, 2026

The 10-Milligram Rush — Cannabis Drinks Bulk Up Before the Federal Clock Runs Out

There is a quiet arms race underway in the cannabis beverage aisle, and this week it got louder.

Read more →

Holden Leads

Reach every licensed buyer

Phone, email, website and licence data for dispensaries, cultivators, manufacturers, distributors and labs, verified weekly against state regulators.